A 24-year-old Pennsylvania man was indicted on Jan. 2 on a terrorism charge and lying to federal authorities after he allegedly traveled to Lebanon and Syria in an effort to join the terrorist group Hezbollah, the Department of Justice announced.
Jack Danaher Molloy was indicted by a grand jury on charges of attempting to support the foreign terrorist organization Hezbollah and making false statements involving international terrorism to a department or agency of the United States, according to the DOJ.
Molloy allegedly attempted to provide material support and resources to Hezbollah in Lebanon, Syria, and in the Western District of Pennsylvania from approximately August 2024 through December 2024, according to the indictment and the criminal complaint.
Molloy was arrested in Chicago on Dec. 6 and transported to Pittsburgh on Dec. 30. He is a dual citizen of the United States and Ireland, and served in the U.S. Army for a short time.
Molloy allegedly traveled to Lebanon in August and tried to join the terrorist group. […]
— Read More: www.theepochtimes.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.